thrombomodulin (Schering)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namethrombomodulin (Schering)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor IIa inhibitors
TargetsProthrombin
Therapy Area/IndicationsBlood Coagulation DisordersThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer Schering Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer Schering Pharma AG
Active IndicationsN/A
Inactive IndicationsBlood Coagulation DisordersThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A